Table 2: The parameters of disease severity in groups at baseline.

ADA (no Uveitis) (n=12) ADA (Uveitis) (n=13) ETA (no Uveitis) (n=49) p between ADA (no Uveitis) and ADA (Uveitis) p between ADA (no Uveitis) and ETA (no Uveitis) p between ADA (Uveitis) and ETA (no Uveitis)
Erythrocyte sedimentation rate, mm/h 22.5 (13: 47.25) 29 (12: 37) 20 (15: 29) 0.604 0.723 0.808
C-reactive protein, mg/l 20.17 (2.01: 31.7) 6.85 (1: 9) 5.42 (1.17: 19.14) 0.299 0.197 0.735
Morning stiffness, min 60 (30: 195) 60 (20: 120) 60 (0: 86.25) 0.721 0.328 0.474
Painful joint count 5.5 (2: 16.5) 3 (2: 5) 2 (2: 5) 0.236 0.168 0.951
Swollen joint count 4 (2: 15.75) 3 (2: 5) 3 (2: 6) 0.308 0.637 0.439
Limited joint count 5.5 (2: 16.5) 4 (2: 5) 3 (2: 5) 0.426 0.361 0.881
Active joint count 5.5 (2: 16.5) 3 (2: 5) 3 (2: 5) 0.236 0.384 0.515
patVAS 81.5 (56.75: 88.5) 58 (50: 64) 58 (45: 80) 0.057 0.073 0.555
phyVAS 89.5 (69.25: 95) 70 (64: 86) 70 (58: 90) 0.134 0.106 0.897
CHAQ 2 (0.88: 2.5) 0.88 (0.5: 1.25) 1 (0.7: 1.88) 0.036 0.055 0.224
JADAS71 22.25 (18.45: 35.1) 17 (13.2: 20.6) 18.1 (13.6: 21.3) 0.068 0.056 0.697